Trial Profile
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq and Rotarix.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2018
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary) ; Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Pharmacodynamics
- 07 Oct 2018 Results of a retrospective analysis assessing the impact of antibiotic exposure on serological responses to Rotavirus Vaccination (n=1174) presented at the IDWeek 2018
- 20 Sep 2013 Planned end date changed from 1 Aug 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 20 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov..